TY  - RPRT
TI  - Pembrolizumab-Chemotherapy Versus Pembrolizumab in Head and Neck Squamous Cell Carcinoma: A PD-L1 CPS-Stratified Analysis of Updated KEYNOTE-048 Data.
AU  - Shasha Xing
AU  - Songchen Shi
AU  - Meile Jin
AU  - Liuqing Han
AU  - Jinwen Wang
AU  - Fujun Han
PY  - 2026
DO  - 10.1002/ijc.70649
UR  - https://pubmed.ncbi.nlm.nih.gov/42433120/
ID  - 42433120
ER  -